Skip to Main Content

Paper Details

Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Artery Disease.
J Vasc Interv Radiol
3
2023
PTX, Paclitaxel, Peripheral Artery Disease, amputations, paclitaxel, patients
Cardiovascular Agents, Drug-Eluting Stents, Endovascular Procedures, Femoral Artery, Humans, Paclitaxel, Peripheral Arterial Disease, Popliteal Artery, Treatment Outcome, Vascular Patency
Author NameAffiliation
Sourbha S DaniComparative Effective Research Institute, Lahey Hospital and Medical Center
Arjun MajithiaComparative Effective Research Institute, Lahey Hospital and Medical Center
Henry SsemagandaComparative Effective Research Institute, Lahey Hospital and Medical Center
Susan RobbinsComparative Effective Research Institute, Lahey Hospital and Medical Center
Daniel J BertgesUniversity of Vermont Medical Center
Jens Eldrup-JorgensenMaine Medical Center
Art Sedrakyan
Michael S LevyComparative Effective Research Institute, Lahey Hospital and Medical Center
Flora S Siami
Karen E Joynt MaddoxWashington University School of Medicine
Michael MathenyVanderbilt University Medical Center
Eric A SecemskyBeth Israel Deaconess Medical Center
Frederic S ResnicComparative Effective Research Institute, Lahey Hospital and Medical Center
  • 1 - 13

Datasets

Release 1.2